- Country: Czech Republic
- Summary: Antineoplastics and Immunomodulators 2024
- CZT Ref No: 98523598
- Deadline: 10 Apr 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 66560000
- Notice Type: Tender
- Document Ref. No.: 145435-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public contract is the supply of medicinal products intended for the therapy of serious chronic diseases in the total expected volume of 122,952 individual doses of medicinal products.
Delivery of preva number of tasks will be carried out based on the results of the completed procurement procedure for a period of four years from the signing of the purchase contract.
Cytostatic drug containing the active ingredient cemiplimab
Ampoules containing 350 mg of cemiplimab, expected annual volume of 50 ampoules (doses); ATC L01FF06
Immune preparation containing active substance dupilumab
Ampoules containing 300 mg of dupilumab, estimated annual volume of 1,600 ampoules (doses); ATC D11AH05
Cytostatic agent containing the active substance sacituzumab govitecan
Ampoules containing 200 mg of sacituzumab govitecan, estimated annual volume of 600 ampoules (doses); ATC L01FX17
Immune preparation with effective contentsubstances plerixafor
Ampoules containing 24 mg of plerixafor, estimated annual volume of 12 ampoules (doses); ATC L03AX16
Cytostatic agent containing the active substance isatuximab
Ampoule containing 100 mg of isatuximab, estimated annual volume of 120 ampoules (dosage); ampoule containing 500 mg isatuximab, estimated annual volumeem 100 ampoules (dosage); ATC L01FC02
Immunosuppressant containing the active substance sarilumab
Ampoule containing 200 mg of sarilumab, estimated annual volume of 90 ampoules (dose); ATC L04AC14
Immunosuppressant containing the active substance ponesimod
P.o. form containing 20 mg of ponesimod, estimated annual volume of 15,120 is... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAntineoplastics and Immunomodulators 2024 - Czech Tender
The UNIVERSITY HOSPITAL IN PILSEN, a Government sector organization in Czech Republic, has announced a new tender for Antineoplastics and Immunomodulators 2024. This tender is published on CzechTenders under CZT Ref No: 98523598 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-04-10.
The estimated tender value is CZK 66560000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
